Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of GBP 200.93 billion. The enterprise value is 227.52 billion.

Market Cap	200.93B
Enterprise Value	227.52B

Important Dates

The next estimated earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	Mar 16, 2026

Share Statistics

Current Share Class	2.47B
Shares Outstanding	n/a
Shares Change (YoY)	-1.34%
Shares Change (QoQ)	-0.40%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	80.17%
Float	2.47B

Valuation Ratios

The trailing PE ratio is 14.82 and the forward PE ratio is 21.41.

PE Ratio	14.82
Forward PE	21.41
PS Ratio	4.16
PB Ratio	5.14
P/TBV Ratio	62.23
P/FCF Ratio	21.88
P/OCF Ratio	16.42
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.44, with an EV/FCF ratio of 24.78.

EV / Earnings	16.78
EV / Sales	4.74
EV / EBITDA	10.44
EV / EBIT	12.60
EV / FCF	24.78

Financial Position

The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.96.

Current Ratio	1.54
Quick Ratio	0.96
Debt / Equity	0.96
Debt / EBITDA	1.71
Debt / FCF	4.09
Interest Coverage	18.03

Financial Efficiency

Return on equity (ROE) is 36.88% and return on invested capital (ROIC) is 25.91%.

Return on Equity (ROE)	36.88%
Return on Assets (ROA)	12.04%
Return on Invested Capital (ROIC)	25.91%
Return on Capital Employed (ROCE)	22.54%
Weighted Average Cost of Capital (WACC)	5.22%
Revenue Per Employee	652,746
Profits Per Employee	183,280
Employee Count	74,000
Asset Turnover	0.51
Inventory Turnover	2.32

Taxes

In the past 12 months, Merck & Co. has paid 2.08 billion in taxes.

Income Tax	2.08B
Effective Tax Rate	13.31%

Stock Price Statistics

The stock price has increased by +39.19% in the last 52 weeks. The beta is 0.28, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y)	0.28
52-Week Price Change	+39.19%
50-Day Moving Average	118.19
200-Day Moving Average	99.18
Relative Strength Index (RSI)	36.67
Average Volume (20 Days)	10,852

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.48

Income Statement

In the last 12 months, Merck & Co. had revenue of GBP 48.30 billion and earned 13.56 billion in profits. Earnings per share was 5.41.

Revenue	48.30B
Gross Profit	37.30B
Operating Income	18.18B
Pretax Income	15.65B
Net Income	13.56B
EBITDA	21.63B
EBIT	18.18B
Earnings Per Share (EPS)	5.41

Balance Sheet

The company has 10.82 billion in cash and 37.55 billion in debt, giving a net cash position of -26.72 billion.

Cash & Cash Equivalents	10.82B
Total Debt	37.55B
Net Cash	-26.72B
Net Cash Per Share	n/a
Equity (Book Value)	39.13B
Book Value Per Share	15.79
Working Capital	11.29B

Cash Flow

In the last 12 months, operating cash flow was 12.24 billion and capital expenditures -3.06 billion, giving a free cash flow of 9.18 billion.

Operating Cash Flow	12.24B
Capital Expenditures	-3.06B
Depreciation & Amortization	3.43B
Net Borrowing	8.42B
Free Cash Flow	9.18B
FCF Per Share	n/a

Margins

Gross margin is 77.21%, with operating and profit margins of 37.64% and 28.08%.

Gross Margin	77.21%
Operating Margin	37.64%
Pretax Margin	32.41%
Profit Margin	28.08%
EBITDA Margin	44.77%
EBIT Margin	37.64%
FCF Margin	19.01%

Dividends & Yields

This stock pays an annual dividend of 2.47, which amounts to a dividend yield of 2.24%.

Dividend Per Share	2.47
Dividend Yield	2.24%
Dividend Growth (YoY)	0.56%
Years of Dividend Growth	4
Payout Ratio	44.79%
Buyback Yield	1.34%
Shareholder Yield	3.58%
Earnings Yield	6.75%
FCF Yield	4.57%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 3.5 and a Piotroski F-Score of 5.

Altman Z-Score	3.5
Piotroski F-Score	5